BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31718603)

  • 1. Optimal allocation of HIV resources among geographical regions.
    Kedziora DJ; Stuart RM; Pearson J; Latypov A; Dierst-Davies R; Duda M; Avaliani N; Wilson DP; Kerr CC
    BMC Public Health; 2019 Nov; 19(1):1509. PubMed ID: 31718603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
    Stuart RM; Grobicki L; Haghparast-Bidgoli H; Panovska-Griffiths J; Skordis J; Keiser O; Estill J; Baranczuk Z; Kelly SL; Reporter I; Kedziora DJ; Shattock AJ; Petravic J; Hussain SA; Grantham KL; Gray RT; Yap XF; Martin-Hughes R; Benedikt CJ; Fraser-Hurt N; Masaki E; Wilson DJ; Gorgens M; Mziray E; Cheikh N; Shubber Z; Kerr CC; Wilson DP
    J Int AIDS Soc; 2018 Apr; 21(4):e25097. PubMed ID: 29652100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations.
    Shattock AJ; Kerr CC; Stuart RM; Masaki E; Fraser N; Benedikt C; Gorgens M; Wilson DP; Gray RT
    J Int AIDS Soc; 2016; 19(1):20627. PubMed ID: 26928810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
    Benedikt C; Kelly SL; Wilson D; Wilson DP;
    Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
    Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
    PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice.
    Fraser N; Kerr CC; Harouna Z; Alhousseini Z; Cheikh N; Gray R; Shattock A; Wilson DP; Haacker M; Shubber Z; Masaki E; Karamoko D; Görgens M
    J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S213-20. PubMed ID: 25723987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using allocative efficiency analysis to inform health benefits package design for progressing towards Universal Health Coverage: Proof-of-concept studies in countries seeking decision support.
    Fraser-Hurt N; Hou X; Wilkinson T; Duran D; Abou Jaoude GJ; Skordis J; Chukwuma A; Lao Pena C; Tshivuila Matala OO; Gorgens M; Wilson DP
    PLoS One; 2021; 16(11):e0260247. PubMed ID: 34843546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies.
    Shattock AJ; Benedikt C; Bokazhanova A; Đurić P; Petrenko I; Ganina L; Kelly SL; Stuart RM; Kerr CC; Vinichenko T; Zhang S; Hamelmann C; Manova M; Masaki E; Wilson DP; Gray RT
    PLoS One; 2017; 12(2):e0169530. PubMed ID: 28207809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of constraints on the efficient allocation of resources for HIV prevention.
    Stopard IJ; McGillen JB; Hauck K; Hallett TB
    AIDS; 2019 Jun; 33(7):1241-1246. PubMed ID: 30649065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.
    Kelly SL; Martin-Hughes R; Stuart RM; Yap XF; Kedziora DJ; Grantham KL; Hussain SA; Reporter I; Shattock AJ; Grobicki L; Haghparast-Bidgoli H; Skordis-Worrall J; Baranczuk Z; Keiser O; Estill J; Petravic J; Gray RT; Benedikt CJ; Fraser N; Gorgens M; Wilson D; Kerr CC; Wilson DP
    Lancet HIV; 2018 Apr; 5(4):e190-e198. PubMed ID: 29540265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for allocating CDC's HIV prevention resources in the United States.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    Health Care Manag Sci; 2011 Mar; 14(1):115-24. PubMed ID: 21184183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the impact of state budget cuts and redirection of prevention resources on the HIV epidemic in 59 California local health departments.
    Lin F; Lasry A; Sansom SL; Wolitski RJ
    PLoS One; 2013; 8(3):e55713. PubMed ID: 23520447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV prevention where it is needed most: comparison of strategies for the geographical allocation of interventions.
    Anderson SJ; Ghys PD; Ombam R; Hallett TB
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29220115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal investment in a portfolio of HIV prevention programs.
    Zaric GS; Brandeau ML
    Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing HIV in injection drug users: choosing the best mix of interventions for the population.
    Wilson AR; Kahn JG
    J Urban Health; 2003 Sep; 80(3):465-81. PubMed ID: 12930884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optima TB: A tool to help optimally allocate tuberculosis spending.
    Goscé L; Abou Jaoude GJ; Kedziora DJ; Benedikt C; Hussain A; Jarvis S; Skrahina A; Klimuk D; Hurevich H; Zhao F; Fraser-Hurt N; Cheikh N; Gorgens M; Wilson DJ; Abeysuriya R; Martin-Hughes R; Kelly SL; Roberts A; Stuart RM; Palmer T; Panovska-Griffiths J; Kerr CC; Wilson DP; Haghparast-Bidgoli H; Skordis J; Abubakar I
    PLoS Comput Biol; 2021 Sep; 17(9):e1009255. PubMed ID: 34570767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allocating HIV prevention funds in the United States: recommendations from an optimization model.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    PLoS One; 2012; 7(6):e37545. PubMed ID: 22701571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the use of modelling in resource allocation decisions for HIV and TB.
    Bowring AL; Ten Brink D; Martin-Hughes R; Fraser-Hurt N; Cheikh N; Scott N
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232992
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.